suberoyl bis-hydroxamic acid has been researched along with Follicular Thyroid Carcinoma in 1 studies
suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiao, X | 1 |
| Ning, L | 1 |
| Chen, H | 1 |
1 other study available for suberoyl bis-hydroxamic acid and Follicular Thyroid Carcinoma
| Article | Year |
|---|---|
Notch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors.
Topics: Adenocarcinoma, Follicular; Blotting, Western; Carcinoma, Papillary; Cell Cycle; Cell Proliferation; | 2009 |